|
| Nefiracetam Basic information |
| Nefiracetam Chemical Properties |
Melting point | 151-155°C | Boiling point | 458.5±33.0 °C(Predicted) | density | 1.187±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,Room Temperature | solubility | DMSO: >5mg/mL | pka | 13.77±0.70(Predicted) | form | solid | color | white to off-white | Merck | 14,6439 | InChI | InChI=1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17) | InChIKey | NGHTXZCKLWZPGK-UHFFFAOYSA-N | SMILES | N1(CC(NC2=C(C)C=CC=C2C)=O)CCCC1=O | CAS DataBase Reference | 77191-36-7(CAS DataBase Reference) |
Hazard Codes | Xn | Risk Statements | 22 | WGK Germany | 3 | RTECS | UX9655650 | HS Code | 2933.79.1500 | Toxicity | LD50 in mice (mg/kg): 421 i.v.; 1766 orally (Betzing, 1982) |
| Nefiracetam Usage And Synthesis |
Uses | analgesic, antiinflammatory | Uses | Nefiracetam improves post-ischemia evoke-nonconvulsive seizure by altering pro-inflammatory cytokines. | Definition | ChEBI: Nefiracetam is an organooxygen compound and an organonitrogen compound. It is functionally related to an alpha-amino acid. | Biological Activity | Cognitive enhancer that displays various pharmacological effects. Activates L/N-type calcium channels, cholinergic, monoaminergic and GABAergic systems. Displays potent neuroprotective action in the retinal ischemia-reperfusion model in vivo . | storage | Store at RT |
| Nefiracetam Preparation Products And Raw materials |
|